Thola ulwazi oluthe xaxa ku-neurologist u-Oliver Tobin, M.B., B.Ch., B.A.O., Ph.D.
Asazi ukuthi yini ebangela i-MS, kodwa kunezinye izinto ezingase zikhulise ingozi noma zibangele ukuqala kwayo. Ngakho-ke, nakuba i-MS ingase ibonakale kunoma iyiphi iminyaka, ikakhulukazi ivela kubantu abaneminyaka ephakathi kuka-20 no-40. Amazinga aphansi e-vitamin D nokuvezwa okuncane ekukhanyeni kwelanga, okuvumela umzimba wethu ukuba wenze i-vitamin D, kuhambisana nengozi eyenyuka yokuthuthukisa i-MS. Njengoba abantu abane-MS abanamanani aphansi e-vitamin D bathambekele ekubeni nesifo esinzima. Ngakho-ke abantu abanesisindo esiningi banamathuba amaningi okuthuthukisa i-MS kanye nabantu abane-MS futhi banesisindo esiningi bathambekele ekubeni nesifo esinzima kanye nokuqala okusheshayo kokuthuthuka. Abantu abane-MS nabafuma bathambekele ekubeni nezinye izikhathi zokubuyela, isifo esibi esithuthukayo, kanye nezimpawu ezingathandeki. Abafazi banamathuba amathathu okuba ne-MS enqamula-nqamula kunamadoda. Ingozi ye-MS kubantu abavamile cishe i-0.5%. Uma umzali noma umfowabo noma udadewabo enesifo se-MS, ingozi yakho cishe iphindwe kabili noma cishe i-1%. Ukutheleleka okuthile kubalulekile. Izinhlobo ezihlukahlukene zama-virus ziye zahlanganiswa ne-MS, kufaka phakathi i-Epstein-Barr virus, ebangela i-mono. Ama-latitude aseNyakatho naseningizimu anamazinga aphezulu, kuhlanganise neCanada, i-US enyakatho, i-New Zealand, iningizimu-mpumalanga ye-Australia, neYurophu. Abantu abamhlophe, ikakhulukazi abavela enyakatho yeYurophu, banengozi enkulu. Abantu abavela e-Asia, e-Afrika, nase-Native America banengozi encane. Ingozi encane eyenyuka iyabonakala uma isiguli sesivele sinomdlavuza we-autoimmune thyroid, i-anemia pernicious, i-psoriasis, i-type 1 diabetes, noma isifo sokuvuvukala sezisu.
Okwamanje ayikho i-test eyodwa yokwenza ukuxilongwa kwe-MS. Noma kunjalo, kunezimpawu ezine eziyinhloko ezisiza ekuqinisekiseni ukuxilongwa. Okokuqala, ingabe kunezinhlobo zezimpawu ze-multiple sclerosis? Futhi, lezo zilahleko lombono elinye iso, ukulahleka kwamandla engalo noma umlenze, noma ukuhlupheka komuzwa engalweni noma umlenze okuhlala isikhathi esingaphezu kwamahora angu-24. Okwesibili, ingabe unezinye izinto ezitholakala ekuhlolweni komzimba ezihambisana ne-MS? Okulandelayo, ingabe i-MRI yobuchopho bakho noma umgogodla ihambisana ne-MS? Manje lapha kubalulekile ukuqaphela ukuthi i-95% yabantu abangaphezu kweminyaka engu-40 banesifo esingavamile se-MRI yobuchopho, njengoba nje abaningi bethu sinama-wrinkles olukhuni. Ekugcineni, ingabe imiphumela yokuhlaziywa kwe-spinal fluid ihambisana ne-MS? Udokotela wakho angase akukhuthaze ukuhlolwa kwegazi ukuhlola ezinye izifo ezinazo izimpawu ezifanayo. Bangase futhi bakhuthaze i-OCT test noma i-optical coherence tomography. Lokhu kuyiskena elifushane lobukhulu bezingqimba ngemuva kwamehlo akho.
Ngakho-ke into engcono kakhulu ongayenza uma uphila ne-MS ukufumana iqembu lezokwelapha elithenjiwe lezinhlangano ezingakusiza ukulandelela nokuphatha impilo yakho. Ukuba neqembu lezinhlangano eziningi kubalulekile ekubhekaneni nezimpawu zomuntu siqu ozibhekana nazo. Uma une-MS attack noma ukubuyela, udokotela wakho angase akubhalele ama-corticosteroids ukunciphisa noma ukuthuthukisa izimpawu zakho. Futhi uma izimpawu zakho zokuhlasela zingaphenduli kuma-steroids, enye indlela yi-plasmapheresis noma ukushintshwa kwe-plasma, okuyindlela yokwelapha efana ne-dialysis. Cishe i-50% yabantu abangaphenduli kuma-steroids banokuzuza okukhulu ngesikhathi esifushane sokushintshwa kwe-plasma. Kunezinye izidakamizwa ezingaphezu kuka-20 ezivunyelwe okwamanje zokuvimbela ukuhlaselwa kwe-MS nokuvimbela izifo ezintsha ze-MRI.
Ku-multiple sclerosis, ukumbozwa okuvikelayo ezintweni zezinzwa kulimala futhi kungase kugcinwe kubhujiswe. Lokhu kuboshwe okuvikelayo kubizwa ngokuthi i-myelin. Kuye ngokuthi ukubhujiswa kwezinzwa kwenzeka kuphi, i-MS ingathinta umbono, umuzwa, ukuxhumana, ukuhamba, kanye nokulawula kwesisu noma izisu.
Multiple sclerosis yisifo esibangela ukuphazamiseka kokumbozwa okuvikelayo kwezinzwa. Multiple sclerosis ingabangela ukungathandeki, ubuthakathaka, ukuhlupheka ekuhambeni, ukuguquka kombono nezinye izimpawu. Kuyaziwa nangokuthi yi-MS.
Ku-MS, uhlelo lokuphephakazi lomzimba luhlasele i-sheath evikela ehlanganisa ucingo lwezinzwa, oluaziwa ngokuthi yi-myelin. Lokhu kuphazamisa ukuxhumana phakathi kobuchopho nezinye izingxenye zomzimba. Ekugcineni, isifo singabangela umonakalo ophakade wezingqimba zezinzwa.
Izimpawu ze-MS ziyahlukahluka kuye ngumuntu, indawo yomonakalo ohlelweni lwezinzwa nokuthi umonakalo wezingqimba zezinzwa ukhulu kangakanani. Abanye abantu bayalahlekelwa ikhono lokuhamba bodwa noma ukuhamba nhlobo. Abanye bangaba nezikhathi ezinde phakathi kokuhlasela ngaphandle kwezimpawu ezintsha, okuthiwa yi-remission. Indlela yesifo iyahlukahluka kuye ngohlobo lwe-MS.
Asikho isilondolozi se-multiple sclerosis. Noma kunjalo, kunezinye izindlela zokwelapha ezisiza ekusizeni ukubuyela kokuhlasela, ukuguqula indlela yesifo nokuphatha izimpawu.
Ezinye izimo zihlelwa njengezigaba, kodwa i-multiple sclerosis ihlelwa njengezinhlobo. Izinhlobo ze-MS ziyahlukahluka kuye ngokuthuthuka kwezimpawu kanye nokuqina kokubuyela. Izinhlobo ze-MS zihlanganisa:
Abantu abaningi abane-multiple sclerosis banohlobo oluqamula-nqamula. Bayahlangabezana nezikhathi zezimpawu ezintsha noma ukubuyela okuthuthukayo ezinsukwini noma emaviki futhi ngokuvamile kuyaqina ngokuphelele noma ngokuphelele. Lokhu kubuyela kulandelelwa yizikhathi ezolile zokuthuthukiswa kwesifo ezingase zihlale izinyanga noma iminyaka.
Okungenani i-20% kuya ku-40% yabantu abane-multiple sclerosis enqamula-nqamula ekugcineni bangathuthukisa ukuqhubeka okuzinzile kwezimpawu. Lokhu kuqhubeka kungase kube khona noma kungabi khona izikhathi zokuthuthukiswa futhi kwenzeka phakathi kweminyaka engu-10 kuya kwengu-40 yokuqala kwesifo. Lokhu kuwaziwa ngokuthi yi-secondary-progressive MS.
Ukuwohloka kwezimpawu ngokuvamile kuhlanganisa inkinga yokunyakaza nokuhamba. Izinga lokuqhubeka kwesifo liyahlukahluka kakhulu phakathi kwabantu abane-secondary-progressive MS.
Abanye abantu abane-multiple sclerosis bayahlangabezana nokuqala okuqhubekayo nokuqhubeka okuzinzile kwezimpawu ngaphandle kokubuyela. Lolu hlobo lwe-MS luwaziwa ngokuthi yi-primary-progressive MS.
I-clinically isolated syndrome ibhekisela esigabeni sokuqala sesimo esithinta i-myelin. Ngemva kokuhlolwa okwengeziwe, i-clinically isolated syndrome ingase ixilongwe njenge-MS noma isimo esihlukile.
I-radiologically isolated syndrome ibhekisela ezintweni ezitholakala kwi-MRI yobuchopho nomgogodla obukela njenge-MS kumuntu ongenazo izimpawu ezivamile ze-MS.
Kwisifoqele esiningi, ukumbozwa okuvikelayo emithanjeni yezinzwa, okwaziwa ngokuthi i-myelin, ohlelweni lwezinzwa oluphakathi kulimale. Ngokuya ngendawo yomonakalo ohlelweni lwezinzwa oluphakathi, izimpawu zingase zenzeke, kufaka phakathi ukungabi namuzwa, ukukhahlela, ubuthakathaka, ukushintsha kokubona, izinkinga zesibindi nezamathumbu, izinkinga zokuqonda, noma ukushintsha kwesimo sengqondo, ngokwesibonelo.
Izimpawu zesifoqele esiningi zihlukahluka kuye ngumuntu. Izimpawu zingashintsha phakathi nohambo lwesifo kuye ngokuthi yimiphi imithanjeni yezinzwa eithintekayo.
Izimpawu ezivamile zihlanganisa:
Ukuqhubeka okuncane kokushisa komzimba kungalimaza izimpawu ze-MS isikhashana. Lezi azibhekwa njengokubuya kwezifo ezithile kodwa yi-pseudorelapses.
Yenza i-aphoyintimenti nodokotela wakho noma omunye ochwepheshe wezempilo uma unezinkinga ezikukhathazayo.
Imbangela ye-multiple sclerosis ayaziwa. Kubhekwa njengesiifo esibangelwa yisistimu yomzimba lapho isistimu yomzimba yokulwa nezifo ihlasela izicubu zayo. Ku-MS, isistimu yomzimba yokulwa nezifo ihlasela futhi ibhubhise izinto ezinhlanzi ezihlanganisa futhi zivikele imicu yezinzwa ebuchosheni nasemgogweni wasemuqolo. Le nto ehlanganisa amafutha ibizwa ngokuthi i-myelin.
I-myelin ingafaniswa nokumbozwa kokukhahlela kweentambo zombane. Uma i-myelin eyivikelo yonakele futhi umthambo wezinzwa ukhombile, imiyalezo ehamba kulelo thambo lezinzwa ingase ibe buthakathaka noma ivinjelwe.
Akucace ukuthi kungani i-MS ithuthukela kwabanye abantu hhayi kwabanye. Ukuhlanganiswa kwezinto zofuzo nezinto ezingaphandle kungase kukhulise ingozi ye-MS.
Izici ezandisa ingozi ye-multiple sclerosis zifaka phakathi:
Izinkinga ze-multiple sclerosis zingafaka:
Ukuhlolwa okuphelele kwesistimu yezinzwa kanye nomlando wezokwelapha kuyadingeka ukuze kuhlonishwa i-MS.
Udokotela wezinzwa u-Oliver Tobin, uM.B., uB.Ch., uB.A.O., uPh.D., uyaphendula imibuzo ebuzwa kakhulu mayelana ne-sclerosis ephindaphindayo.
Ngakho-ke abantu abanesisindo esiningi banesilinganiso esiphezulu sokuthuthukisa i-MS kanye nabantu abane-MS abanesisindo esiningi bathambekele ekubeni nesifo esisebenzayo kakhulu kanye nokuqala okusheshayo kokuthuthuka. Ukudla okukhulu okuye kwabonakala kuvikelayo izinzwa yikudla kweMediterranean. Lokhu kudla kuphezulu ezinhlanzini, imifino, namantongomane, futhi kuphansi enyameni ebomvu.
Ngakho-ke lo mbuzo uvela kakhulu ngoba iziguli ezinale sclerosis ephindaphindayo ngezinye izikhathi zingaba nokuwohloka okwesikhashana kwezinkinga zazo ekushiseni noma uma zenza umsebenzi onzima. Into ebalulekile okumele iphawulwe ukuthi ukushisa akubangeli ukuhlaselwa yi-MS noma ukuphindaphinda kwe-MS. Futhi ngakho-ke akubi. Awukwenzi noma yiluphi uhlobo lokulimala oluhlala njalo uma lokhu kwenzeka. Ukuzivocavoca kunconywa kakhulu futhi kuvikelekile ebuchosheni nasemgogweni wamathambo.
Ososayensi abakaqondi ukuthi yiziphi izicubu ze-stem ezilusizo ku-MS, iyiphi indlela yokuzinika noma iyiphi inani lokubapha noma iyiphi isikhathi. Ngakho-ke okwamanje, ukwelashwa kwezicubu ze-stem akuconyiwe ngaphandle kokuba kuvivinywe okungokwelapha.
I-Neuromyelitis optica spectrum disorder noma i-NMOSD ne-MOG-associated disorder zingabangela izici ezifana ne-sclerosis ephindaphindayo. Lezi ziyavame kakhulu kubantu base-Asia noma base-Afrika-Amerika. Futhi udokotela wakho angakuncoma ukuhlolwa kwegazi ukuze kuvinjwe lezi zifo.
Kahle, into ebaluleke kakhulu ngokuba nokuxilongwa kwe-sclerosis ephindaphindayo ukuthi ungumuntu ophakathi kweqembu lakho lezokwelapha. Isikhungo esiphelele se-MS yindawo engcono kakhulu yokuphathwa kwe-sclerosis ephindaphindayo, futhi lokhu ngokuvamile kuhlanganisa odokotela abanolwazi olukhulu e-sclerosis ephindaphindayo, odokotela bezinzwa, kodwa futhi odokotela bezitho zokukhulula, abaphathi bezokwelapha bomzimba kanye nokulungiswa, izazi zengqondo, nabanye abaninzi abahlinzeki abanesithakazelo ekhethekile e-sclerosis ephindaphindayo. Ukuhlanganisa leli qembu elizungezile wena nezidingo zakho ezithile kuzokuthuthukisa imiphumela yakho ngokuhamba kwesikhathi.
Awekho amavivinyo athile e-MS. Ukuxilongwa kunikezwa ngokuhlanganiswa komlando wezokwelapha, ukuhlolwa komzimba, i-MRI kanye nemiphumela yokuphuma komgogodla. Ukuxilongwa kwe-sclerosis ephindaphindayo kuhlanganisa nokukhipha ezinye izimo ezingase ziveze izimpawu ezifanayo. Lokhu kuyaziwa njengokuxilongwa okuhlukile.
Isithombe se-MRI sobuchopho esibonisa izigxobo ezimhlophe ezihlotshaniswa ne-sclerosis ephindaphindayo.
Phakathi nokuphuma komgogodla, okwaziwa nangokuthi i-spinal tap, ngokuvamile ulela eceleni ngamadolo akho aphakanyisiwe esifubeni sakho. Khona-ke inhlanzi ifakwa emgodini womgogodla ngemuva kwakho ophansi ukuze iqoqe i-cerebrospinal fluid ukuze ihlolwe.
Amavivinyo asetshenziswa ukuze kuhlonishwa i-MS angafaka:
Kubantu abaningi abane-relapsing-remitting MS, ukuxilongwa kulula. Ukuxilongwa kusekelwe ephenini lezimpawu ezihlotshaniswa ne-MS futhi kuqinisekiswe yimiphumela yokuhlolwa.
Ukuxilongwa kwe-MS kungaba nzima kubantu abanezinkinga ezingavamile noma isifo esithuthukayo. Ukuhlolwa okwengeziwe kungadingeka.
i-Brain MRI ivame ukusetshenziswa ukuze kusize ekuxilongweni kwe-sclerosis ephindaphindayo.
Asikho ikhambi le-multiple sclerosis. Ukwelashwa kuvame ukugxila ekuqedeni ukubuyiselwa ekuhlaselweni, ukunciphisa ukuphindaphinda, ukuthambisa ukuqhubeka kwesifo nokulawula izimpawu ze-MS. Abanye abantu banezimpawu ezilula kangangokuthi akukho ukwelashwa okudingekayo.
Phakathi nokuhlaselwa kwe-MS, ungase welashwe ngokuthi:
Kunezindlela eziningi zokwelapha eziguqula isifo (DMTs) ze-relapsing-remitting MS. Ezinye zalezi DMTs zingaba usizo lwe-secondary-progressive MS. Eyodwa itholakala kwi-primary-progressive MS.
Iningi lempendulo yomzimba ehlobene ne-MS kwenzeka ezigabeni zokuqala zesifo. Ukwelashwa okunamandla ngalezi zidakamizwa ngokushesha ngangokunokwenzeka kunganciphisa izinga lokuphindaphinda nokuthambisa ukwakheka kwezifo ezintsha. Lezi zindlela zokwelapha zinganciphisa ingozi yezifo nokuwohloka kokukhubazeka.
Eziningi zezindlela zokwelapha eziguqula isifo ezisetshenziswa ekwelapheni i-MS zinezinkinga zempilo ezinzima. Ukukhetha ukwelashwa okulungile kuwe kuncike ezintweni eziningi. Izici zihlanganisa isikhathi sokuthi uke waba nesifo isikhathi esingakanani kanye nezimpawu zakho. Iqembu lakho lokunakekelwa kwezempilo libuye libheke ukuthi ukwelashwa kwangaphambili kwe-MS kuye kwasebenza yini nezinye izinkinga zakho zempilo. Iindleko nokuthi uhlela yini ukuba nezingane esikhathini esizayo nazo zingazici lapho unquma ukwelashwa.
Izinketho zokwelapha ze-relapsing-remitting MS zihlanganisa imithi yokugcoba, yokuluma nokufakwa.
Ukwelashwa okugobekayo kuhlanganisa:
Imiphumela emibi ye-interferons ingase ihlanganise izimpawu ezifana ne-flu kanye nemiphumela yendawo yokugcoba. Uzodinga ukuhlolwa kwegazi ukuze uqaphele ama-enzymes akho e-liver ngoba ukonakala kwe-liver kuyimbangela ebangela umphumela omubi wokusetshenziswa kwe-interferon. Abantu abathinte imithi ye-interferons bangase bathuthukise ama-antibodies anganciphisa ukuthi imithi isebenza kangcono kangakanani.
Imithi ye-Interferon beta. Le mithi isebenza ngokuphazamisa izifo ezihlasela umzimba. Zinganciphisa ukuvuvukala nokukhulisa ukukhula kwama-nerve. Imithi ye-Interferon beta igcobwa phansi kwesikhumba noma emithanjeni. Inganciphisa inani lokuphindaphinda nokwenza kube lula.
Imiphumela emibi ye-interferons ingase ihlanganise izimpawu ezifana ne-flu kanye nemiphumela yendawo yokugcoba. Uzodinga ukuhlolwa kwegazi ukuze uqaphele ama-enzymes akho e-liver ngoba ukonakala kwe-liver kuyimbangela ebangela umphumela omubi wokusetshenziswa kwe-interferon. Abantu abathinte imithi ye-interferons bangase bathuthukise ama-antibodies anganciphisa ukuthi imithi isebenza kangcono kangakanani.
Ukwelashwa kokuluma kuhlanganisa:
Ukwelashwa kokufakwa kuhlanganisa:
I-Natalizumab yenzelwe ukuvimba ukuhamba kwamaseli omzimba angalimaza ukusuka egazini lakho uya ebuchosheni nasemgogodleni wakho. Ingase icatshelwe njengokwelashwa kokuqala kwabanye abantu abane-relapsing-remitting MS noma njengokwelashwa kwesibili kwabanye.
Le mithi ikhuphula ingozi yokutheleleka okukhulu kwe-viral ebuchosheni elibizwa nge-progressive multifocal leukoencephalopathy (PML). Ingozi ikhuphuka kubantu abane-antibodies ezibangela i-PML JC virus. Abantu abangenayo ama-antibodies banezingozi ezincane kakhulu ze-PML.
Le mithi iyasiza ekuthambiseni ukuphindaphinda kwe-MS ngokuqondisa iprotheni ebusweni lamaseli omzimba nokunciphisa amaseli egazi amhlophe. Lo mphumela unganciphisa ukonakala kwama-nerve okubangelwa amaseli egazi amhlophe. Kodwa futhi ikhuphula ingozi yokutheleleka nezinye izimo zomzimba, kuhlanganise ingozi enkulu yezifo zokuzimela ze-thyroid kanye nesifo sezinso esingavamile esibangelwa ukungasebenzi kahle komzimba.
Ukwelashwa nge-alemtuzumab kuhlanganisa izinsuku ezinhlanu ezilandelayo zokufakwa okulandelelwa izinsuku ezintathu zokufakwa ngonyaka olandelayo. Ukusebenza kokufakwa kuyinto evamile nge-alemtuzumab.
I-Alemtuzumab itholakala kuphela ochwepheshe bezempilo ababhalisiwe. Abantu abaphathwa ngale mithi kufanele babhaliswe ohlelweni olukhulu lokuqapha ukuphepha kwemithi. I-Alemtuzumab ngokuvamile icelwa kulabo abane-MS enonya noma njengokwelashwa kwesibili uma ezinye izidakamizwa ze-MS azisebenzi.
Natalizumab (Tysabri). Lena i-monoclonal antibody ebonakale inciphise amazinga okuphindaphinda nokuthambisa ingozi yokukhubazeka.
I-Natalizumab yenzelwe ukuvimba ukuhamba kwamaseli omzimba angalimaza ukusuka egazini lakho uya ebuchosheni nasemgogodleni wakho. Ingase icatshelwe njengokwelashwa kokuqala kwabanye abantu abane-relapsing-remitting MS noma njengokwelashwa kwesibili kwabanye.
Le mithi ikhuphula ingozi yokutheleleka okukhulu kwe-viral ebuchosheni elibizwa nge-progressive multifocal leukoencephalopathy (PML). Ingozi ikhuphuka kubantu abane-antibodies ezibangela i-PML JC virus. Abantu abangenayo ama-antibodies banezingozi ezincane kakhulu ze-PML.
Ocrelizumab (Ocrevus). Le mithi yamukelwe yi-FDA ukwelapha kokubili i-relapsing-remitting ne-primary-progressive forms ze-MS. Lolu lwelo lunciphise izinga lokuphindaphinda kanye nengozi yokukhubazeka okuqhubekayo kwi-relapsing-remitting multiple sclerosis. Iphinde ihambise ukuqhubeka kwesifo se-primary-progressive multiple sclerosis.
Ukuhlolwa kwezokwelapha kubonise ukuthi kunciphise izinga lokuphindaphinda esifweni esiphindaphindayo futhi kuthambise ukuwohloka kokukhubazeka kokubili izinhlobo zesifo.
Alemtuzumab (Campath, Lemtrada). Lolu lwelo luyi-monoclonal antibody oluthambisa amazinga okuphindaphinda minyaka yonke futhi lubonisa izinzuzo ze-MRI.
Le mithi iyasiza ekuthambiseni ukuphindaphinda kwe-MS ngokuqondisa iprotheni ebusweni lamaseli omzimba nokunciphisa amaseli egazi amhlophe. Lo mphumela unganciphisa ukonakala kwama-nerve okubangelwa amaseli egazi amhlophe. Kodwa futhi ikhuphula ingozi yokutheleleka nezinye izimo zomzimba, kuhlanganise ingozi enkulu yezifo zokuzimela ze-thyroid kanye nesifo sezinso esingavamile esibangelwa ukungasebenzi kahle komzimba.
Ukwelashwa nge-alemtuzumab kuhlanganisa izinsuku ezinhlanu ezilandelayo zokufakwa okulandelelwa izinsuku ezintathu zokufakwa ngonyaka olandelayo. Ukusebenza kokufakwa kuyinto evamile nge-alemtuzumab.
I-Alemtuzumab itholakala kuphela ochwepheshe bezempilo ababhalisiwe. Abantu abaphathwa ngale mithi kufanele babhaliswe ohlelweni olukhulu lokuqapha ukuphepha kwemithi. I-Alemtuzumab ngokuvamile icelwa kulabo abane-MS enonya noma njengokwelashwa kwesibili uma ezinye izidakamizwa ze-MS azisebenzi.
I-physical therapy ingakha amandla emisipha futhi ithambelise ezinye zezimpawu ze-MS.
Lezi zindlela zokwelapha zingasiza ekuthambiseni ezinye zezimpawu ze-MS.
I-physical therapy kanye nosizo lokuhamba, uma kudingeka, ingasiza futhi ekulawuleni ubuthakathaka beenyawo nokwenza kube lula ukuhamba.
Ukwelashwa. Uchwepheshe we-physical noma we-occupational angakufundisa imizamo yokwelula nokomelela. Uchwepheshe angakubonisa futhi ukuthi ungasebenzisa kanjani amadivayisi ukwenza kube lula ukwenza imisebenzi yansuku zonke.
I-physical therapy kanye nosizo lokuhamba, uma kudingeka, ingasiza futhi ekulawuleni ubuthakathaka beenyawo nokwenza kube lula ukuhamba.
I-Bruton's tyrosine kinase (BTK) inhibitor iyindlela yokwelapha ehlolwa kwi-relapsing-remitting multiple sclerosis ne-secondary-progressive multiple sclerosis. Isebenza ngokuguqula umsebenzi wamaseli e-B, angamaseli omzimba ohlelweni lwezinzwa oluphakathi.
Enye indlela yokwelapha ehlolwa kubantu abane-MS yi-stem cell transplantation. Lolu lwelo lubhubhisa uhlelo lomzimba lomuntu onale-MS bese ulushintsha ngamaseli e-stem aphilayo. Abacwaningi basacwaninga ukuthi lolu lwelo lunganciphisa yini ukuvuvukala kubantu abane-MS nokwenza kube lula "ukusetha kabusha" uhlelo lomzimba. Imiphumela emibi engenzeka yi-fever kanye ne-infections.
Uhlobo lwe-protein elibizwa nge-CD40L olutholakala kumaseli e-T lubonakale ludlala indima kwi-MS. Izifundo zakamuva zibonise ukuthi ukuvimba le protheni kungasiza ekulawuleni i-MS.
Imithi entsha ebizwa nge-phosphodiesterase inhibitor nayo ihlolwa. Le mithi isebenza ekuthambiseni ukuvuvukala ngokushintsha izimpendulo zesimiso somzimba ezilimazayo ezibonwa kwi-MS.
Abacwaningi nabo bafunda okwengeziwe ngendlela izindlela zokwelapha eziguqula isifo ezisebenza ngayo ekuthambiseni ukuphindaphinda nokunciphisa izifo ezihlobene ne-multiple sclerosis ebuchosheni. Kuyadingeka izifundo ezengeziwe ukuze kunqunywe ukuthi ukwelashwa kungalihambisa yini ukukhubazeka okubangelwa yisifo.
Umshwana wokuzihlangula: I-August iyinkundla yolwazi lwezempilo futhi izimpendulo zayo azihlanganisi iseluleko sezokwelapha. Njalo thintana nochwepheshe bezokwelapha onelayisensi eduze nawe ngaphambi kokwenza noma yiluphi ushintsho.